rhinovirusinduc
bronchiolitisearli
wheez
probabl
import
risk
factor
recurr
wheez
childhood
asthma
mechan
behind
undesir
longterm
sequela
remain
poorli
understood
potenti
factor
includ
atop
inherit
weak
antivir
defens
viral
factor
look
close
previou
report
quantit
rhinoviru
detect
find
rhinoviru
genom
load
bronchiol
shortterm
clinic
outcom
includ
need
intens
care
treatment
condit
howev
higher
rhinoviru
genom
load
relat
sever
andor
durat
acut
lower
respiratori
tract
ill
studi
report
discrimin
respons
system
corticosteroid
term
less
recurr
wheez
data
link
rhinoviru
genom
load
clinic
outcom
howev
discord
studi
subject
asthma
shown
clinic
associ
reason
rel
small
sampl
earlier
studi
examin
clinic
signific
rhinoviru
genom
load
bronchiol
children
sever
bronchiol
aim
prospect
investig
whether
rhinoviru
genom
load
standard
nasopharyng
aspir
npa
sampl
associ
shortterm
outcom
bronchiol
basi
previou
literatur
hypothesi
higher
rhinoviru
genom
load
bronchiol
associ
wors
shortterm
outcom
analysi
combin
data
multicent
prospect
cohort
studi
children
younger
year
hospit
bronchiol
studi
use
protocol
us
studi
tabl
articl
onlin
repositori
wwwjacionlineorg
wherea
finnish
counterpart
studi
carri
finnish
site
winter
season
see
detail
recruit
articl
onlin
repositori
wwwjacionlineorg
studi
protocol
approv
ethic
committe
particip
hospit
studi
commenc
obtain
written
inform
consent
guardian
investig
interview
guardian
use
standard
questionnair
conduct
hospit
chart
review
clinic
data
npa
sampl
perform
use
standard
protocol
sampl
store
later
viru
diagnost
includ
realtim
pcr
adenoviru
coronavirus
enteroviru
human
metapneumoviru
influenza
viru
type
b
novel
parainfluenza
viru
type
rhinoviru
respiratori
syncyti
viru
rsv
b
bordetella
pertussi
mycoplasma
pneumonia
previous
describ
rhinoviru
genom
load
quantifi
use
realtim
rtpcr
number
amplif
cycl
need
posit
pcr
test
result
cycl
threshold
ct
ct
valu
provid
semiquantit
measur
genom
load
highli
signific
invers
linear
relationship
genom
load
ct
valu
see
detail
viru
diagnost
articl
method
section
onlin
repositori
www
jacionlineorg
primari
outcom
measur
hospit
length
stay
lo
day
secondari
outcom
measur
intens
care
treatment
defin
use
mechan
ventil
continu
posit
airway
pressur
andor
intub
inpati
stay
regardless
locat
andor
admiss
intens
care
unit
tertil
rhinoviru
ct
valu
permit
classif
rhinoviru
genom
load
group
low
ct
intermedi
ct
high
ct
associ
rhinoviru
genom
load
outcom
analyz
use
unadjust
multivari
logist
regress
model
sever
sensit
analys
perform
assess
robust
find
analys
perform
use
sa
sa
institut
cari
nc
see
detail
outcom
statist
method
onlin
repositori
wwwjacionlineorg
enrol
children
bronchiol
site
children
rhinoviru
compris
analyt
cohort
us
children
finnish
children
among
children
median
age
month
interquartil
rang
month
boy
nonhispan
white
two
hundr
sixti
children
lo
day
requir
intens
care
treatment
see
detail
demograph
clinic
cours
tabl
articl
onlin
repositori
wwwjacionlineorg
overal
signific
associ
rhinoviru
genom
load
invers
ct
valu
risk
lo
day
risk
intens
care
treatment
either
unadjust
analys
multivari
model
adjust
patientlevel
variabl
cluster
patient
within
site
p
fig
see
tabl
articl
onlin
repositori
wwwjacionlineorg
likewis
sensit
analysi
focus
first
episod
infant
younger
month
show
signific
associ
p
see
tabl
similarli
rhinoviru
genom
load
signific
associ
outcom
countri
see
fig
b
articl
onlin
repositori
wwwjacionlineorg
coinfect
see
tabl
articl
onlin
repositori
wwwjacionlin
org
atopi
statu
fig
b
see
tabl
articl
onlin
repositori
wwwjacionlineorg
comorbid
statu
see
tabl
articl
onlin
repositori
wwwjacionlin
org
respiratori
distress
sever
score
see
tabl
articl
onlin
repositori
wwwjacionlineorg
summari
found
associ
rhinoviru
genom
load
shortterm
outcom
bronchiol
hypothesi
justifi
basi
previou
clinic
data
also
support
vitro
data
although
multipl
viral
infect
rel
common
sever
bronchiol
interplay
virus
poorli
understood
coinfect
rsvand
rhinoviru
link
sever
shortterm
outcom
bronchiol
compar
rsv
alon
found
link
rhinoviru
genom
load
coinfect
outcom
even
examin
rhinovirusonli
group
associ
null
moreov
investig
interact
rhinoviru
genom
load
atop
statu
interest
atop
children
appear
suscept
nonatop
children
rhinovirusinduc
wheez
consid
larg
sampl
size
care
standard
npa
sampl
viru
diagnost
done
protocol
singl
laboratori
result
truli
suggest
signific
associ
rhinoviru
genom
load
lo
day
need
intens
care
treatment
although
studi
suggest
rhinoviru
genom
load
clinic
relev
children
older
month
associ
support
data
report
result
contrast
direct
associ
rsv
genom
load
shortterm
outcom
bronchiol
specul
host
respons
infect
may
import
viru
load
determin
shortterm
clinic
cours
rhinovirusinduc
bronchiol
studi
potenti
limit
first
bronchiol
clinic
diagnosi
without
common
intern
definit
includ
children
age
year
recurr
wheez
result
howev
remain
consist
analysi
restrict
children
experienc
first
episod
breath
difficulti
infanc
age
month
second
clinic
decis
eg
hospit
admissiondischarg
intens
care
treatment
base
standard
criteria
may
caus
variabl
care
howev
signific
associ
persist
adjust
cluster
hospit
level
third
one
might
argu
sampl
upper
respiratori
tract
reflect
condit
lower
respiratori
tract
nasal
airway
epitheli
cell
may
respond
differ
bronchial
epitheli
cell
rhinoviru
infect
knowledg
data
comparison
rhinoviru
genom
load
upper
lower
airway
sampl
relat
symptom
fourth
one
could
also
argu
whether
measur
peak
rhinoviru
replic
due
lack
longitudin
sampl
peak
viru
concentr
typic
occur
hour
infect
experiment
model
durat
prehospit
symptom
typic
day
rhinovirusinduc
bronchiol
time
window
first
hour
hospit
may
optim
fifth
sequenc
rhinovirus
last
result
may
generaliz
outpati
clinic
studi
subject
hospit
challeng
futur
studi
includ
care
standard
analysi
ie
standard
housekeep
gene
investig
viremia
ie
link
compromis
clinic
outcom
viru
genotyp
ie
rhinoviru
speci
rapid
evolut
viru
care
analysi
replicationtranscript
statu
viru
ie
separ
analysi
positiveand
negativestrand
viru
rna
find
call
attent
need
detail
analysi
virolog
along
host
respons
genet
investig
predictor
shortterm
outcom
sever
rhinovirusinduc
bronchiol
editor
chronic
rhinosinus
cr
common
around
adult
shown
associ
reduc
qualiti
life
studi
focus
adolesc
specif
therefor
want
estim
preval
cr
adolesc
evalu
burden
symptom
swedish
populationbas
birth
cohort
barn
children
allergi
milieu
stockholm
epidemiolog
studi
bams
consist
children
recruit
mean
age
month
previous
describ
detail
studi
base
children
baselin
particip
followup
novemb
may
complet
question
cr
see
tabl
articl
onlin
repositori
wwwjacionlineorg
everyon
fulfil
criteria
cr
accord
european
posit
paper
rhinosinus
contact
telephon
symptom
affirm
structur
interview
n
median
time
questionnair
telephon
interview
month
adolesc
ongo
symptom
n
ask
particip
clinic
followup
nasal
endoscopi
olfactori
threshold
test
sniffin
stick
burghart
messtechnik
gmbh
wedel
germani
sinonas
outcom
test
diseasespecif
qualityoflif
questionnair
compar
healthrel
qualityoflif
hrqol
remain
particip
bams
followup
gener
visual
analog
scale
va
use
tabl
articl
onlin
repositori
www
jacionlineorg
descript
sniffin
stick
eqva
present
method
section
articl
onlin
repositori
wwwjacionlineorg
nasal
endoscopi
perform
specialist
ear
nose
throat
diseas
mw
mh
applic
topic
anesthesia
naphazolinelidocain
spray
inspect
mean
anterior
nasoscopi
perform
afterward
endoscopi
rigid
endoscop
case
fiberopt
endoscopi
perform
estim
preval
cr
present
method
section
articl
onlin
repositori
x
test
independ
use
comparison
dichotom
variabl
p
valu
less
consid
statist
signific
eqva
score
present
median
valu
percentil
median
valu
compar
quantil
regress
analys
conduct
stata
statist
softwar
version
statacorp
colleg
station
tex
among
bams
birth
cohort
report
symptom
upper
airway
last
month
n
report
symptom
cr
see
fig
articl
onlin
repositori
wwwjacionlin
org
children
criteria
epo
use
preval
n
fortytwo
adolesc
fulfil
adult
children
criteria
time
telephon
interview
adolesc
still
ongo
symptom
cr
see
fig
clinic
examin
adolesc
still
fulfil
symptom
criteria
cr
correspond
preval
tabl
clinic
examin
endoscop
sign
cr
found
adolesc
correspond
preval
none
subject
nasal
polyp
enlarg
adenoid
undergon
sinu
surgeri
adolesc
cr
often
allerg
rhiniti
symptom
vs
p
asthma
vs
p
cough
month
longer
vs
p
compar
without
cr
tabl
median
eqva
score
lower
compar
rest
popul
vs
p
p
adjust
sex
tabl
present
analysi
combin
data
multicent
prospect
cohort
studi
children
hospit
bronchiol
use
similar
protocol
one
studi
unit
state
finland
studi
perform
part
marc
marc
program
emerg
medicin
network
wwwemnetusaorg
collabor
particip
hospit
studi
design
set
particip
method
data
collect
use
studi
report
previous
use
standard
protocol
enrol
children
younger
year
hospit
attend
physician
diagnosi
bronchiol
exclus
criteria
consist
previou
enrol
delay
hour
transfer
particip
hospit
origin
hospit
patient
treat
discret
treat
physician
institut
review
board
particip
hospit
approv
studi
collect
npa
child
place
supin
ml
normal
salin
instil
nari
suction
cathet
use
remov
mucu
procedur
perform
nostril
sampl
collect
nare
ml
normal
salin
suction
cathet
clear
tube
ensur
standard
volum
aspir
obtain
collect
npa
sampl
ad
transport
medium
sampl
immedi
place
ice
within
hour
collect
store
within
hour
collect
realtim
rtpcr
use
detect
rna
respiratori
virus
rhinoviru
rsv
type
b
parainfluenza
viru
type
influenza
viru
type
b
novel
human
metapneumoviru
coronavirus
enteroviru
realtim
pcr
use
detect
dna
pathogen
includ
adenoviru
pneumonia
b
pertussi
test
routin
conduct
baylor
colleg
medicin
detail
primer
probe
describ
previous
upper
lower
limit
rhinoviru
detect
ct
respect
purpos
analys
focus
rhinoviru
categor
ct
valu
tertil
classifi
patient
rhinoviru
genom
load
statu
group
low
ct
intermedi
ct
high
ct
compar
patient
demograph
characterist
medic
histori
hospit
cours
rhinoviru
genom
load
statu
use
chisquar
kruskalw
test
appropri
examin
associ
genom
load
statu
outcom
construct
logist
regress
model
first
fit
unadjust
model
includ
genom
load
statu
independ
variabl
second
construct
multivari
model
adjust
patientlevel
variabl
ie
age
sex
race
gestat
age
histori
wheez
histori
eczema
comorbid
medic
disord
viral
coinfect
statu
rhinoviru
plu
rsv
rhinoviru
plu
nonrsv
pathogen
chose
potenti
confound
basi
clinic
plausibl
priori
knowledg
adjust
marker
acut
sever
eg
vital
sign
retract
durat
symptom
bronchiol
hospit
consid
intermedi
factor
associ
interest
model
use
gener
estim
equat
account
patient
cluster
hospit
level
perform
seri
sensit
analys
assess
robust
find
first
examin
associ
rhinoviru
genom
load
primari
outcom
model
ct
valu
continu
variabl
us
cohort
finnish
cohort
separ
second
confirm
similar
associ
cohort
combin
us
finnish
data
set
repeat
analysi
use
restrict
definit
children
bronchiolitisthat
younger
month
without
histori
wheez
third
stratifi
analysi
coinfect
statu
rhinoviru
rhinoviru
plu
rsv
rhinoviru
plu
nonrsv
pathogen
last
also
stratifi
analysi
children
atop
statu
ie
histori
eczema
analys
perform
use
sa
sa
institut
cari
nc
result
present
proport
ci
median
interquartil
rang
odd
ratio
ci
p
valu
p
consid
statist
signific
